General and Transplant Surgery Department, University of L'Aquila, L'Aquila, Italy.
General and Transplant Surgery Department, University of L'Aquila, L'Aquila, Italy.
Transplant Proc. 2021 May;53(4):1272-1274. doi: 10.1016/j.transproceed.2021.03.019. Epub 2021 Apr 22.
Transplant renal artery stenosis (TRAS) is a common vascular complication after kidney transplantation, leading to worsening or refractory hypertension, deterioration in renal function, and possible cause of graft loss. Early diagnosis and an appropriate treatment are crucial for organ preservation. Endovascular treatment, including percutaneous transluminal angioplasty and stent implantation, is considered the first-line therapy for TRAS. Here we report the case of a 69-year-old woman with end-stage renal disease for chronic kidney disease not biopsy proven, who underwent a kidney transplant from expanded criteria donors on December 2018. Postoperative course was characterized by delayed graft function. Doppler ultrasonography (US) showed an increase of peak systolic velocity at the origin of the renal artery, and parvus-tardus waveform in periferic graft arteries and an abdominal computed tomography scan confirmed a stenosis at the origin of the main renal artery (TRAS). The patient underwent a percutaneous transluminal angioplasty. It was not possible to place a stent at the particular location of the stenosis at the anastomosis. Despite the improvement of the graft's perfusion, monitored with Doppler US, the patient showed a very poor improvement in renal function and remained on hemodialysis for months. A percutaneous needle biopsy reported a normal renal parenchyma and excluded acute rejection. During this period, the patient received immunosuppressive therapy. About 6 months after the transplant, the patient had an unexpected and slow renal function recovery until she was weaned completely from hemodialysis.
移植肾动脉狭窄(TRAS)是肾移植后的一种常见血管并发症,可导致高血压恶化或难治、肾功能恶化,并可能导致移植物丢失。早期诊断和适当的治疗对器官保存至关重要。血管内治疗,包括经皮腔内血管成形术和支架植入术,被认为是 TRAS 的一线治疗方法。在此,我们报告了一位 69 岁女性的病例,该女性患有原因不明的慢性肾脏病终末期,于 2018 年 12 月接受了来自扩大标准供体的肾移植。术后过程的特点是移植物功能延迟。多普勒超声(US)显示肾动脉起源处的收缩期峰值速度增加,外围移植物动脉的 parvus-tardus 波形,并通过腹部计算机断层扫描证实主肾动脉起源处狭窄(TRAS)。患者接受了经皮腔内血管成形术。尽管在吻合处狭窄的特定位置放置支架是不可能的,但在多普勒 US 监测下,移植物的灌注得到了改善。尽管移植物的灌注得到了改善,但患者的肾功能仍很差,并且在几个月内仍需要进行血液透析。经皮针活检报告肾实质正常,排除了急性排斥反应。在此期间,患者接受了免疫抑制治疗。在移植后约 6 个月,患者的肾功能意外且缓慢恢复,直到她完全摆脱血液透析。